Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.

O Clegg, D; J Reda, D; Mejias, E; W Cannon, G; H Weisman, M; Taylor, T; Budiman-Mak, E; D Blackburn, W; B Vasey, F; L Mahowald, M; J Cush, J; R Schumacher, H; L Silverman, S; P Alepa, F; E Luggen, M; R Cohen, M; Makkena, R; M Haakenson, C; H Ward, R; J Manaster, B; J Anderson, R; R Ward, J; G Henderson, W

doi:10.1002/art.1780391210

Public

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.

Shared by NobleBlocks on Dec 1, 1996 • 12:00 AM UTC

Authors:

D O Clegg

D J Reda

E Mejias

Abstract

OBJECTIVE: To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective for the treatment of active psoriatic arthritis (PsA) resistant to nonsteroidal antiinflammatory drug therapy. METHODS: Two hundred twenty-one patients with PsA were recruited from 15 clinics, randomized (do...

Discussions